Ractigen’s RAG-17 ALS Data Shines at AAN 2025: Earns Top Award, Phase I Advances
Final results from an Investigator-Initiated Trial presented for the first time, demonstrating favorable safety, significant target engagement, and encouraging clinical & biomarker signals Abstract honored with prestigious "Abstracts of Distinction" award by AAN Science Committee, recognizing top quality and interest Phase I clinical trial for RAG-17 advancing as planned with dosing successfully completed for the first two cohorts...
Darnatein, an OSR Company, Broadens Intellectual Property Protection for Innovative Osteoarthritis Treatment Technology
SEOUL, South Korea, April 9, 2025 /PRNewswire/ -- Darnatein, a wholly-owned subsidiary of OSR Holdings, Inc. (NASDAQ: OSRH), today announces that it has successfully secured an additional international patent for its protein-based osteoarthritis treatment technology, marking a significant step in its expansion into the global market. Activin/BMP7 Chimera Protein Technology Registered...
Asia Health & Medlab Asia Rebrands to WHX and WHX Labs in Kuala Lumpur and Bangkok
KUALA LUMPUR, Malaysia, April 9, 2025 /PRNewswire/ -- The global event organisation leader Informa Markets revealed a major rebranding of its healthcare exhibitions portfolio which resulted in the formation of WHX (World Health Expo). WHX rebrands its healthcare events across Southeast Asia to WHX Kuala Lumpur, WHX Labs Kuala Lumpur, WHX Bangkok and WHX Labs Bangkok. Through this strategic...
Corti Launches Medical Dictation API, Democratizing Access to Premium Dictation Technology
New Specialized Medical Dictation API and SDK Enables Developers to Build Trustworthy Dictation Solutions in Record Time COPENHAGEN, Denmark, April 9, 2025 /PRNewswire/ -- Corti, the leading AI infrastructure provider for healthcare, today opened access to its healthcare-specialized Dictation API, powered by its Solo foundation model. By launching this specialized API, Corti is...
ENERGIZER LAUNCHES THE WORLD’S FIRST 3-IN-1 CHILD SHIELD™ COIN-CELL LITHIUM RANGE IN MALAYSIA
The new Energizer 3-in-1 Child Shield™ features the exclusive new colour alert technology, child-resistant packaging, and a non-toxic bitter coating to create the most comprehensive safety solution for Malaysian families. PETALING JAYA, Malaysia, April 9, 2025 /PRNewswire/ -- Energizer Malaysia introduces the world's first and only coin lithium battery equipped with three levels of child-protection technology to...
BaseCare Medical (2170.HK) Unveils First Smart Home Sperm Analyzer, Pioneering “B+C” Full-Scenario Intelligent Expansion
SUZHOU, China, April 9, 2025 /PRNewswire/ -- BaseCare Medical, a trailblazer in reproductive health and China's first publicly traded company in the assisted reproductive IVD sector, has secured regulatory approval for its portable home sperm quality analyzer (model: BKP200). As the nation's first consumer-facing device for at-home viable sperm testing, this milestone not only underscores the company's technical prowess...
GC Biopharma Receives MFDS Approval for World’s First Recombinant Anthrax Vaccine
YONGIN, South Korea, April 9, 2025 /PRNewswire/ -- GC Biopharma announced 09. Apr. 2025 that the Korean Ministry of Food and Drug Safety (MFDS) has approved its anthrax vaccine, BARYTHRAX, jointly developed by GC Biopharma and the Korea Disease Control and Prevention Agency (KDCA). With the approval by MFDS, BARYTHRAX has become...
Siemens Healthineers and Singapore General Hospital Announce Strategic Partnership to Advance Healthcare Innovation
Five-year strategic partnership to improve patient care Focus on developing new technologies, improving diagnostics and treatment protocols, providing training and knowledge sharing. SINGAPORE, April 8, 2025 /PRNewswire/ -- Siemens Healthineers and Singapore General Hospital (SGH) have recently signed a Memorandum of Understanding (MOU) to establish a five-year strategic partnership...
Remegen Announces Exciting Results of Telitacicept Phase 3 Clinical Trial for Patients with Generalized Myasthenia Gravis
YANTAI, China, April 9, 2025 /PRNewswire/ -- On April 8, 2025 (UTC-7), impressive results of the Phase 3 clinical trial (NCT05737160) evaluating the efficacy and safety of Telitacicept (synonym: RC18; brand name: 泰爱®) in patients with generalized myasthenia gravis (gMG) were presented during the Late-Breaking Science Session at the American Academy of Neurology (AAN)...
Alpro Pharmacy Now Offers Free AIA Vitality Health Check to Support Early Disease Detection
KUALA LUMPUR, Malaysia, April 9, 2025 /PRNewswire/ -- Millions of Malaysians are at risk of serious health complications due to undiagnosed and unmanaged non-communicable diseases (NCDs), such as diabetes, hypertension, high cholesterol, and obesity. According to the National Health and Morbidity Survey (NHMS) 2023, more than 2 million adults are living with at least three of these conditions, and over half a million Malaysians (2.5%...
